source
- Novartis pays $125 million to acquire Sironax’s brain-delivery platformNovartis has exercised an option to buy Sironax’s platform for delivering large molecules across the blood‑brain barrier, with a $125 million payment due at closing. The technology is intended to…
- Experts urge more representative enrollment in clinical trialsA panel of regulators and industry leaders gathered to discuss how clinical trials can better reflect the diversity of patient populations. The discussion included officials from the U.S. Food and…